Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Pradere

Showing results (191-200 of 412) with videos related to

Pageof 42
Sort By:
Prostate Cancer and Prostatic Diseases|October 8, 2025
Prognostic factors of PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer: a systematic review and meta-analysisTakafumi Yanagisawa, Akihiro Matsukawa, Paweł Rajwa, et al.
European Urology Focus|July 26, 2023
Repeat Transurethral Resection for Non-muscle-invasive Bladder Cancer: An Updated Systematic Review and Meta-analysis in the Contemporary EraTakafumi Yanagisawa, Tatsushi Kawada, Markus von Deimling, et al.
World Journal of Urology|May 28, 2021
Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic reviewEkaterina Laukhtina, Reza Sari Motlagh, Keiichiro Mori, et al.
International Journal of Clinical Oncology|November 10, 2021
Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysisTakafumi Yanagisawa, Keiichiro Mori, Satoshi Katayama, et al.
European Urology|July 30, 2017
Benefits and Harms of Treatment of Asymptomatic Bacteriuria: A Systematic Review and Meta-analysis by the European Association of Urology Urological Infection Guidelines PanelBela Köves, Tommaso Cai, Rajan Veeratterapillay, et al.
Central European Journal of Urology|January 27, 2022
Association of statins use and mortality outcomes in prostate cancer patients who received androgen deprivation therapy: a systematic review and meta-analysisAbdulmajeed Aydh, Reza Sari Motlagh, Mishari Alshyarba, et al.
European Urology Open Science|April 27, 2023
Sarcopenia Predicts Disease Progression in Patients with T1 High-grade Non-muscle-invasive Bladder Cancer Treated with Adjuvant Intravesical Bacillus Calmette-Guérin: Implications for Decision-making?Francesco Soria, David D'Andrea, Maurizio Barale, et al.
Clinical Genitourinary Cancer|July 30, 2025
Comparative Assessment of Chemotherapy Followed by Consolidative Radical Cystectomy Versus Chemoradiation for Clinically Node-Positive Urothelial Carcinoma of the BladderAleksander Ślusarczyk, Pietro Scilipoti, Roberto Contieri, et al.
International Journal of Cancer|November 27, 2023
Role of clinicopathological variables in predicting recurrence and survival outcomes after surgery for non-metastatic renal cell carcinoma: Systematic review and meta-analysisMuhammad Majdoub, Takafumi Yanagisawa, Fahad Quhal, et al.
Critical Reviews in Oncology/Hematology|December 13, 2021
Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomesEkaterina Laukhtina, Reza Sari Motlagh, Keiichiro Mori, et al.
Pageof 42

Showing results (191-200 of 412) with videos related to

Sort By:
Pageof 42
Prostate Cancer and Prostatic Diseases|October 8, 2025
Prognostic factors of PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer: a systematic review and meta-analysisTakafumi Yanagisawa, Akihiro Matsukawa, Paweł Rajwa, et al.
European Urology Focus|July 26, 2023
Repeat Transurethral Resection for Non-muscle-invasive Bladder Cancer: An Updated Systematic Review and Meta-analysis in the Contemporary EraTakafumi Yanagisawa, Tatsushi Kawada, Markus von Deimling, et al.
World Journal of Urology|May 28, 2021
Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic reviewEkaterina Laukhtina, Reza Sari Motlagh, Keiichiro Mori, et al.
International Journal of Clinical Oncology|November 10, 2021
Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysisTakafumi Yanagisawa, Keiichiro Mori, Satoshi Katayama, et al.
European Urology|July 30, 2017
Benefits and Harms of Treatment of Asymptomatic Bacteriuria: A Systematic Review and Meta-analysis by the European Association of Urology Urological Infection Guidelines PanelBela Köves, Tommaso Cai, Rajan Veeratterapillay, et al.
Central European Journal of Urology|January 27, 2022
Association of statins use and mortality outcomes in prostate cancer patients who received androgen deprivation therapy: a systematic review and meta-analysisAbdulmajeed Aydh, Reza Sari Motlagh, Mishari Alshyarba, et al.
European Urology Open Science|April 27, 2023
Sarcopenia Predicts Disease Progression in Patients with T1 High-grade Non-muscle-invasive Bladder Cancer Treated with Adjuvant Intravesical Bacillus Calmette-Guérin: Implications for Decision-making?Francesco Soria, David D'Andrea, Maurizio Barale, et al.
Clinical Genitourinary Cancer|July 30, 2025
Comparative Assessment of Chemotherapy Followed by Consolidative Radical Cystectomy Versus Chemoradiation for Clinically Node-Positive Urothelial Carcinoma of the BladderAleksander Ślusarczyk, Pietro Scilipoti, Roberto Contieri, et al.
International Journal of Cancer|November 27, 2023
Role of clinicopathological variables in predicting recurrence and survival outcomes after surgery for non-metastatic renal cell carcinoma: Systematic review and meta-analysisMuhammad Majdoub, Takafumi Yanagisawa, Fahad Quhal, et al.
Critical Reviews in Oncology/Hematology|December 13, 2021
Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomesEkaterina Laukhtina, Reza Sari Motlagh, Keiichiro Mori, et al.
Pageof 42